Herein, to study if OXT treatment has a beneficial effect on beta cells, we used streptozotocin (STZ)-induced diabetic mouse model which suffers from beta cell damage and insulin secretion impairment which resemble T1D and late-stage T2D, but does not have overeating or obesity. The gene discussed is OXT; the disease is Obesity.